GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grown Rogue International Inc (XCNQ:GRIN) » Definitions » Peter Lynch Fair Value

Grown Rogue International (XCNQ:GRIN) Peter Lynch Fair Value : N/A (As of Dec. 12, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Grown Rogue International Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Grown Rogue International's Peter Lynch Fair Value or its related term are showing as below:



XCNQ:GRIN's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.435
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Grown Rogue International Peter Lynch Fair Value Historical Data

The historical data trend for Grown Rogue International's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grown Rogue International Peter Lynch Fair Value Chart

Grown Rogue International Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Oct19 Oct20 Oct21 Oct22
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Grown Rogue International Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Mar24 Jun24 Sep24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Grown Rogue International's Peter Lynch Fair Value

For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grown Rogue International's Price-to-Peter-Lynch-Fair-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Grown Rogue International's Price-to-Peter-Lynch-Fair-Value falls into.



Grown Rogue International Peter Lynch Fair Value Calculation

Grown Rogue International's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0.003
=N/A

Grown Rogue International's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was C$0.00.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Grown Rogue International  (XCNQ:GRIN) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Grown Rogue International's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.90/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grown Rogue International Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Grown Rogue International's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Grown Rogue International Business Description

Traded in Other Exchanges
Address
550 Airport Road, Medford, OR, USA, 97504
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States.
Executives
Abhilash Patel Director
Lp Bengal Catalyst Fund 10% Security Holder
Stephen Mark Gledhill Director
Jakob Iotte Senior Officer
Adam Michael Barnard August Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
J. Obie Strickler 10% Security Holder, Director, Senior Officer
Sean Kenneth Conacher Director
Tom L. Fortner Senior Officer
Robert John Rigg Senior Officer
Jacques Habra Senior Officer